Related Experiment Video
Updated: Jul 10, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients
Dede Sit1, Ali Kemal Kadiroglu, Hasan Kayabasi
1Department of Nephrology, Dicle University Medical Faculty, Diyarbakir, Turkey. drdede75@hotmail.com
Insights
This study found no link between bone turnover markers and bone density in hemodialysis patients, though most had osteopenia or osteoporosis. Lumbar spine bone density was lower than femoral neck bone density.
Area of Science:
- Nephrology
- Endocrinology
- Bone Metabolism
Background:
- End-stage renal disease significantly alters bone and mineral metabolism.
- Osteoporosis is a growing concern in patients undergoing hemodialysis (HD).
Purpose of the Study:
- To investigate the relationship between bone mineral density (BMD) and biochemical markers of bone turnover in hemodialysis patients.
- To assess BMD at the lumbar spine and femoral neck and correlate it with biochemical markers.
Main Methods:
- Seventy uremic patients on maintenance HD were evaluated.
- Bone densitometry (dual energy x-ray absorptiometry) measured BMD at the lumbar spine and femoral neck.
- Biochemical markers of bone turnover (calcium, phosphorus, PTH, alkaline phosphatase, etc.) were measured pre-HD.
Main Results:
- A high prevalence of osteopenia/osteoporosis was observed: 82.8% at the lumbar spine and 64.3% at the femoral neck.
- No statistically significant association was found between BMD and biochemical markers of bone turnover.
- Lumbar spine BMD T-scores were significantly worse than femoral neck BMD T-scores.
Conclusions:
- There is a lack of correlation between biochemical markers of bone turnover and bone mass measurements in hemodialysis patients.
- Elevated alkaline phosphatase and parathyroid hormone levels may predict renal osteodystrophy, but not adynamic bone disease or osteoporosis.
Abstract:
End-stage renal disease is closely associated with changes in bone and mineral metabolism. In recent times, osteoporosis has become important among hemodialysis (HD) patients. In this study, the investigators sought to evaluate the relationship between bone mineral density (BMD) and biochemical markers of bone turnover among HD patients. A total of 70 uremic patients on a maintenance HD program for at least 1 y were enrolled in the study. All patients were treated with conventional bicarbonated HD for 5 h through the use of low-flux hollow-fiber dialyzers. Bone densitometry was measured by dual energy x-ray absorptiometry in the lumbar spine (LS) and the femoral neck (FN). BMD was classified according to World Health Organization criteria on the basis of BMD T scores. Biochemical bone turnover markers such as calcium, phosphorus, ionized calcium, intact parathyroid hormone, alkaline phosphatase, plasma bicarbonate, blood pH, serum albumin, and hematocrit levels were measured before the HD session in the morning. Male patients (n=37; 52.9%; mean age, 46.2+/-17.0 y) were assigned to a single study group, and female patients (n=33; 47.1%; mean age, 44.0+/-13.1 y) to another. Mean duration of HD treatment was 33.7+/-28.5 mo in females and 33.0+/-26.0 mo in males. Among all patients, BMD T scores in the osteopenia/osteoporosis range were observed at the LS in 58 patients (82.8%) and at the FN in 45 patients (64.3%). According to BMD measurements in FN T score, 10% of patients (n=7) were osteoporotic, 54.3% (n=38), osteopenic, and 35.7% (n=25), normal. On the other hand, in LS T score, the results were 47.1% (n=33) osteoporotic, 35.7% (n=25), osteopenic, and 17.1% (n=12), normal. No statistically significant association was found in osteopenia/osteoporosis between sexes according to FN and LS T score (P=.542, P=.267, respectively). No significant relationship was noted between BMD and biochemical markers of bone turnover. A positive correlation was found between FN T scores of BMD and age (r=.413, P=.000). BMD T scores within the range of scores for osteopenia/osteoporosis were observed in 78.5% of patients at the LS and in 58.5% of patients at the FN. The investigators concluded that no correlation could be found between markers of bone turnover and bone mass measurements in both skeletal regions. LS T score results were worse than FN T score results. Elevated alkaline phosphastase levels combined with high intact parathyroid hormone levels are predictive of renal osteodystrophy but not of adynamic bone disease/osteoporosis.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Skeleton and Calcium Homeostasis
Chronic Kidney Disease II: Clinical Manifestations
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Chronic Kidney Disease III: Interprofessional Care
